Freshfields has advised Veloxis Pharmaceuticals, Inc., a subsidiary of Asahi Kasei Group. Veloxis Pharmaceuticals, Inc., a subsidiary of Asahi Kasei Group, has reached an agreement to…
Veloxis Acquires AiCuris in €780 Million Transaction
Freshfields has advised Veloxis Pharmaceuticals, Inc., a subsidiary of Asahi Kasei Group. Veloxis Pharmaceuticals, Inc., a subsidiary of Asahi Kasei Group, has reached an agreement to…